Neuromuscular Disorders in Pediatric Respiratory Disease

JB Taylor, DG Ingram, O Kupfer… - Clinics in Chest …, 2024 - chestmed.theclinics.com
The ability to manage complex pediatric neuromuscular patients at home has rapidly
evolved with improving technology. Now both invasive and non-invasive ventilatory options …

Gene therapies for RyR1-related myopathies

I Marty, M Beaufils, J Fauré, J Rendu - Current Opinion in Pharmacology, 2023 - Elsevier
Myopathies related to variations in the RYR1 gene are genetic diseases for which the
therapeutic options are sparse, in part because of the very large size of the gene and …

Specificities of the DMD Gene Mutation Spectrum in Russian Patients

E Zinina, M Bulakh, A Chukhrova, O Ryzhkova… - International Journal of …, 2022 - mdpi.com
Duchenne/Becker muscular dystrophy (DMD/BMD) is the most common form of muscular
dystrophy, accounting for over 50% of all cases. In this regard, in Russia we carry out a …

Genetic counseling for the dystrophinopathies—Practice resource of the National Society of Genetic Counselors

AM Pickart, AS Martin, BN Gross… - Journal of Genetic …, 2024 - Wiley Online Library
The dystrophinopathies encompass the phenotypically variable forms of muscular dystrophy
caused by pathogenic variants in the DMD gene. The dystrophinopathies include the most …

Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial

M Schiava, MP McDermott, J Broomfield, KR Abrams… - Neurology, 2024 - AAN Enterprises
Background and Objectives Clinical trials in Duchenne muscular dystrophy (DMD) require 3–
6 months of stable glucocorticoids, and the primary outcome is explored at 48–52 weeks …

Longitudinal changes in magnetic resonance imaging biomarkers of the gluteal muscle groups and functional ability in Duchenne muscular dystrophy: a 12-month …

Y Song, K Xu, H Xu, Y Guo, R Xu, H Fu, W Yuan… - Pediatric …, 2023 - Springer
Background Quantitative magnetic resonance imaging (MRI) is considered an objective
biomarker of Duchenne muscular dystrophy (DMD), but the longitudinal progression of MRI …

CISD3 is required for Complex I function, mitochondrial integrity, and skeletal muscle maintenance

HB Marjault, O Karmi, L Rowland, TT Nguyen… - bioRxiv, 2023 - biorxiv.org
Mitochondria play a central role in muscle metabolism and function. In skeletal muscles, a
unique family of iron-sulfur proteins, termed CISD proteins, support mitochondrial function …

Real world safety and exploratory efficacy of gene therapy for patients with 5q-Spinal Muscular Atrophy in a Brazilian cohort

R Mendonca, A Ortega, C Matsui Jr, V Van Der Linden… - 2023 - researchsquare.com
Spinal muscular atrophy (SMA) is a motor neuron disease associated with progressive
muscle weakness, ventilatory failure, and reduced survival. Onasemnogene abeparvoves is …

A Multidisciplinary Approach Improves Sexual Health Care for Youth with Duchenne Muscular Dystrophy

E Barrera, JM Baronas, S Sutherland, A Rohan… - The Journal of …, 2024 - Elsevier
We sought to determine the prevalence of sexual health counseling in patients with
Duchenne muscular dystrophy in a single-institution setting. Keywords related to sexual …

[HTML][HTML] Focal anticoagulation by somatic gene transfer: towards preventing cardioembolic stroke

M Kadian, CY Kok, D Ravindran, F Passam… - Heart, Lung and …, 2023 - Elsevier
Cardioembolic stroke (CS) has emerged as a leading cause of ischaemic stroke (IS);
distinguished by thrombi embolising to the brain from cardiac origins; most often from the left …